Abstract Background In Germany, inpatient hospital and rehabilitation facilities are two main settings for the delivery of cancer care. Epidemiology and demography are major forces
Abstract Background The Motivational Interviewing and Medication Review in Coronary Heart Disease (MIMeRiC) randomized controlled trial investigated the effects of a pharmacist-led
A retrospective cost-effectiveness analysis in a single-centre Turkish cohort that confirms ODX RS reduces unnecessary chemotherapy and improves cost-effectiveness compared to clinicopathological assessment alone, consistent with TAILORx trial findings but without new primary efficacy data.
Retrospective cost-of-illness analysis in a single centre quantifying direct per-patient syncope costs (€1,765.31 mean) and demonstrating high diagnostic testing burden; provides descriptive evidence on practice patterns and potential guideline-driven savings but lacks comparative intervention or control arm.